Doctor Jerrold Rosenbaum has been recognized as one of the world's leading experts in Mood and Anxiety Disorders, with a special focus on pharmacotherapy to treat these conditions. In fact, his career has focused on the development of new therapies for Major Depression, Treatment Resistant Depression and Panic Disorder.  

Through his research, he has designed and conducted numerous clinical trials that have expanded the understanding of these disorders, as well as longitudinal studies that have sought to identify risk and protective factors in the psychopathology of children predisposed to Anxiety and Depressive Disorders, including issues of genetics, behavior and brain structures in children at risk for developing Mood Disorders. 

He has also held a number of important positions, including serving as Director of the Department of Psychiatry at Massachusetts General Hospital, where he has supervised more than 600 physicians and researchers. He has also co-founded Psy Therapeutics and Sensorium Therapeutics, companies dedicated to the discovery of new psychiatric and neurological drugs. In addition, he has directed the Center for the Neuroscience of Psychedelics, where he has explored how psychedelics can change the brain and offer new therapeutic approaches for Psychiatric Disorders. 

Likewise, his work has been recognized internationally with multiple awards, such as the prestigious C. Charles Burlingame, for her contribution to psychiatric research, and the Joseph B. Martin Dean's Leadership Award, given by Harvard Medical School for her commitment to the advancement of women in medicine. In turn, he has been awarded the Ellis Island Medal of Honor and has been a Fellow Emeritus of the American College of Neuropsychopharmacology. He has also written more than 400 scientific articles and 20 books.

• Director of the Department of Psychiatry at Massachusetts General Hospital, United States
• Co-founder of Psy Therapeutics and Sensorium Therapeutics 
• Director of the Center for the Neuroscience of Psychedelics 
• Medical Degree from Yale University 
• Member of: 
• American College of Neuropsychopharmacology